Royalty Monetization Transactions

Royalty monetization transactions have become a significant and favored source of financing to biopharmaceutical companies in recent years.

In this session, partners Andrew R. Mariniello and Conor F. Larkin will discuss the different structures employed in such transactions, describe the key issues to be considered by sellers and their investment partners, and explain how companies and inventors utilize royalty monetization transactions to raise capital.